Cetirizina

Zirtec, Reactine, Formistin e altri

Bibliografia - Quali fonti bibliografiche per Cetirizina?

1. Agenzia Italiana del farmaco – AIFA, farmaci e Gravidanza, 2016, http://www.farmaciegravidanza.gov.it/ (accesso: aprile 2016).


2. Baroody F.M., Naclerio R.M., Allergy, 2000, 55 (S64), 17.


3. Bernheim J. et al., Agents Actions Suppl., 1991, 34, 269.


4. Buch J.C., Quick Review of Pharmacology, 2010, ver 3.


5. Church M.K., Church D.S., Ind. J. Dermatol., 2013, 58 (3), 219.


6. Cheria-Sammari S. et al., Clin. Exp. Allergy, 1995, 25 (8), 729.


7. Derakhshandeh K. et Mohebbi M., Res. Pharm. Sci., 2009, 4 (2), 113.


8. Einarson A. et al., Ann. Allergy Asthma Immunol., 1997, 78 (2), 183.


9. Etwel F. et al., J. Obstet. Gyneacol., 2014, 34 (5), 392.


10. Fong D.G. et al., J. Clin. Gastroenterology, 2000, 31 (3), 250.


11. Food and Drug Administration – FDA, Drug Safety Comunication – FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names), 2025, 16 May https://www.fda.gov/media/186542/download?attachment


12. Hafeez F., Maibach H., Skin Theray Lett., 2013, 18 (5), 5.


13. Horsmans Y et al., J. Clin. Pharm., 33 (10), 929.


14. Lefebvre R.A. et al., Int. J. Clin. Pharm. Res., 1988, 8 (6), 463.


15. Leurs R. et al., Clin. Exp. Allergy, 2002, 32, 489.


16. Gillard M. et al., Mol. Pharm., 2002, 61 (2), 391.


17. Matzke G.R. et al., Ann. Allergy, 1987, 59 (6), 25.


18. Mirshahpanah P., Maibach H.I., Contact. Dermatitis, 2007, 56 (3), 125.


19. Naclerio R.M., Laryngoscope, 1989, 99 (6), 596.


20. Raulin-Gaignari H. et al., Arch Pediatr., 2013, 20 (12), 1329.


21. U.S. national Library of Medicine, Toxnet – LactMed, 2016, 1 aprile http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~AYACVQ:2 (accesso: aprile 2016).


22. Vane J., Botting R., FASEB J., 1987, 1 (2), 89.


23. Weber-Schoendorfer C., Schaefer C., Reprod. Toxicol., 2008, 26 (1), 19.